Facial palsy-induced blepharospasm relieved by a Bangerter foil [3]

Movement Disorders

Volumn 20, Issue 9, 2005, Pages 1231-1232

  Sagili, Suresh ^a   Malhotra, Raman ^a   Elston, John ^b  

^a QUEEN VICTORIA HOSPITAL   (United Kingdom)

^b OXFORD EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; BLEPHAROSPASM; BLINKING; CASE REPORT; EYELID CLOSURE; FACIAL NERVE PARALYSIS; FEMALE; FOIL; HUMAN; LETTER; PAROTID GLAND TUMOR; PRIORITY JOURNAL; SPECTACLES; SYMPTOMATOLOGY; VISUAL ACUITY;

ADULT; BLEPHAROSPASM; BOTULINUM TOXIN TYPE A; FACIAL PARALYSIS; FEMALE; HUMANS; NEUROMUSCULAR AGENTS;

EID: 27744563586     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20621     Document Type: Letter

References (7)

1. Miwa H, Kondo T, Mizuno Y. Bells palsy induced blepharospasm. J Neurol 2002;249:452-454.
2. Baker RS, Sun WS, Hasan SA, et al. Maladaptive neural compensatory mechanisms in Bells palsy induced blepharospasm. Neurology 1997;49:223-229.
3. Valls- Sole J, Montero J. Movement disorders in patients with peripheral facial palsy. Mov Disord 2003;18:1424-1435.
4. Chuke JC, Baker RJ, Porter JD. Bells palsy-associated blepharospasm relieved by aiding eyelid closure. Ann Neurol 1996-268.
5. Elston JS, Marsden CD. The significance of ophthalmological symptoms in idiopathic bleparhospasm. Eye 1988;2:435-449.
6. Mitsuyu M, Zimmer EM. Bangerter occlusives versus spherical convex lenses in the evaluation of visual acuity by visually evoked cortical potentials. Dev Ophthalmol 1984;9:115-122.
7. Patel BC, Taylor S, Digre K, Warner J, Swallow C. Management of photophobia in blepharospasm with FL-41 tinted glasses. Fall Scientific Symposium of the American Society of Ophthalmic and Plastic and Reconstructive Surgery, 2003. p 116.